开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
据伊朗媒体Fars News:伊朗代理石油部长将陪同伊朗总统佩泽希齐扬出席10月27日在莫斯科举行的第八届天然气出口国峰会。
2026-10-24
据伊朗媒体Fars News:伊朗代理石油部长将陪同伊朗总统佩泽希齐扬出席10月27日在莫斯科举行的第八届天然气出口国峰会。
返回
其他消息
2026-10-24
The Wall Street Journal, citing people familiar with the matter, reports the Trump administration plans to lift 50% tariffs on certain Canadian agricultural and forestry products, with an announcement possible as soon as Friday; scope and timing remain subject to change. Washington may raise tariffs on other Canadian goods to offset the reduction. The move is intended to help Maine Republican Senator Susan Collins and other Republican candidates ahead of the midterm elections. Trump imposed 50%
The Wall Street Journal, citing people familiar with the matter, reports the Trump administration plans to lift 50% tariffs on certain Canadian agricultural and forestry products, with an announcement possible as soon as Friday; scope and timing remain subject to change. Washington may raise tariffs on other Canadian goods to offset the reduction. The move is intended to help Maine Republican Senator Susan Collins and other Republican candidates ahead of the midterm elections. Trump imposed 50% duties on roughly $20bn of Canadian goods in late August. Last month the US exempted some items while adding others, leaving the overall trade value affected broadly unchanged. White House officials said any formal tariff decision will be announced by the administration.
2026-10-24
Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the resul
Conference data published Saturday show Amgen’s Imdelltra combined with AstraZeneca’s Imfinzi cut the risk of death by 58% versus Imfinzi alone in extensive‑stage small‑cell lung cancer. Median overall survival was 21.1 months for the combo versus 12.7 months for Imfinzi monotherapy. Imfinzi is currently the post‑chemotherapy standard for patients without progression after first‑line chemo. Amgen CMO Paul Burton said earlier use of Imdelltra produced greater clinical benefit and called the result unprecedented for advancing treatment in this indication.
Chat with us
, powered by
LiveChat